Fundz

Chromocell Therapeutics reported raising $750,000 in an initial SEC Form D filing, from an offering of $750,000

PUBLIC · PTHSAug 06, 2024

Amount Raised

$750,000

$750,000 sold, per SEC Form D (first sale Jul 24, 2024)

Round Type

Venture

DurhamBiotechnologyHealthcareHealth CareTherapeuticsPharmaceutical

Quick answer

Pelthos Therapeutics raised $750,000 in a funding round, dated July 24, 2024. Pelthos Therapeutics is based in Durham, North Carolina, United States.

How much did Pelthos Therapeutics raise?
Pelthos Therapeutics raised $750,000 in a funding round on July 24, 2024.
What does Pelthos Therapeutics do?
Pelthos Therapeutics Inc. was formerly known as Chromocell Therapeutics Corp. Pelthos Therapeutics specializes in developing treatments for molluscum contagiosum infections.
Where is Pelthos Therapeutics based and how big is it?
Pelthos Therapeutics is based in Durham, North Carolina, United States. Fundz records about 83 employees.
Who are the decision-makers at Pelthos Therapeutics?
Fundz holds 4 contacts at Pelthos Therapeutics, including the Chief Commercial Officer (CCO). Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at Pelthos Therapeutics, and when

A new round usually means Pelthos Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Pelthos Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Pelthos Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Pelthos Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Pelthos Therapeutics

Location

4020 Stirrup Creek Drive

Durham, North Carolina, United States

About

Pelthos Therapeutics Inc. was formerly known as Chromocell Therapeutics Corp. Pelthos Therapeutics specializes in developing treatments for molluscum contagiosum infections. The company is known for its FDA-approved drug ZELSUVMI, which is the first prescription treatment for home use. Pelthos is committed to advancing patient care through innovative therapeutic solutions. It operates as a subsidiary of Ligand Pharmaceuticals.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Pelthos Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

4 contacts
Verified contactsSai R., Chief Commercial Officer (CCO) hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Pelthos Therapeutics's next move

See what Strategic adds

Pelthos Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.